One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

As sales of its COVID vaccine plummet, Novavax is looking ahead toward other novel vaccines, brought to market with the help ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

Department of Health and Human Services Secretary Robert F. Kennedy Jr. paused a $240 million contract to create a new coronavirus vaccine.

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

Triumphs of COVID-19 included rapid vaccine development and scientific collaboration. But the tragedies were numerous.

Improving our public health infrastructure so people once again trust science and expertise is essential before the next ...

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. “It still feels kind of incomplete,” said ...

Covid-19 is the illness called by the SARS-CoV-2 virus, which emerged in Wuhan, China, in late 2019. The ensuing pandemic has killed millions worldwide. Vaccines have made the condition much less ...

The COVID-19 virus spreads mainly through exposure to airborne droplets infected with the virus. While it's possible to be infected with COVID by coming in contact with a surface with the virus on ...